Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick

    Editors Pick - Page 6

    Tramadol supplied globally from India as psychotropic substance: UN body

    Tramadol supplied globally from India as psychotropic substance: UN body

    Medical Dialogues Bureau29 Feb 2020 2:54 PM IST
    Globally, most of the tramadol, which is not an internationally controlled substance, that was seized from 2013 to 2017 was reported to have...
    Covid-19 Impact: NPPA asks drugmakers to submit availablility data of 58 APIs, details

    Covid-19 Impact: NPPA asks drugmakers to submit availablility data of 58 APIs, details

    Medical Dialogues Bureau28 Feb 2020 4:26 PM IST
    New Delhi: In the light of coronavirus outbreak worldwide, the apex drug regulator National Pharmaceutical Pricing Authority (NPPA) has identified 58...
    Ensure that there is no hoarding, blackmarketing of medicines: NPPA chief tells states on Covid-19 outbreak

    Ensure that there is no hoarding, blackmarketing of medicines: NPPA chief tells states on Covid-19 outbreak

    Medical Dialogues Bureau27 Feb 2020 3:00 PM IST
    State Governments and UTs are requested to closely monitor the production and availability of APIs and their formulations to prevent black marketing...
    USFDA identifies 20 drugs with shortage risks due to coronavirus outbreak

    USFDA identifies 20 drugs with shortage risks due to coronavirus outbreak

    Medical Dialogues Bureau26 Feb 2020 3:54 PM IST
    NEW YORK - The U.S. Food and Drug Administration has contacted producers of about 20 drugs that either source all of their main ingredients from or...
    BA/BE study applications have to be processed in 15 days: CDSCO

    BA/BE study applications have to be processed in 15 days: CDSCO

    Medical Dialogues Bureau25 Feb 2020 12:50 PM IST
    New Delhi: In order to streamline the applications process by various pharma companies, the CDSCO in its notice has recently mandated that BA/BE...
    USV not dominant player, hence no case: CCI dismisses petition by pharma wholesaler

    USV not dominant player, hence no case: CCI dismisses petition by pharma wholesaler

    MD bureau24 Feb 2020 1:23 PM IST
    New Delhi: Noting that the drug firm USV does not seem to enjoy the dominant position in the portfolio of medicines that it sells and hence no case...
    Following SC orders, CDSCO asks Pharma manfacturers submit data on 66 fixed-dose combinations

    Following SC orders, CDSCO asks Pharma manfacturers submit data on 66 fixed-dose combinations

    MD bureau23 Feb 2020 11:45 AM IST
    New Delhi: In continuation of the series of directives that the FDC Division, Central Drugs Standard Control Organization (CDSCO), Directorate General...
    Violation of price capping of Coronary stent to attract NPPA action; Minister

    Violation of price capping of Coronary stent to attract NPPA action; Minister

    Farhat Nasim22 Feb 2020 4:42 PM IST
    "Institutions such as hospitals/nursing homes/clinics utilizing Coronary Stents for Angioplasty are bound to abide by the ceiling prices fixed by the...
    Niti Aayog meets Top pharma execs to find ways to mitigate coronavirus impact; DoP seeks export ban on 12 APIs

    Niti Aayog meets Top pharma execs to find ways to mitigate coronavirus impact; DoP seeks export ban on 12 APIs

    Medical Dialogues Bureau21 Feb 2020 11:58 AM IST
    The meeting was attended by Biocon's Kiran Mazumdar Shaw, Zydus' Pankaj Patel and Dr Reddy's Laboratories' Satish Reddy and other top pharma execs
    Anglo-French co Novacyt  launches CE-IVD Marked novel coronavirus diagnostics test

    Anglo-French co Novacyt launches CE-IVD Marked novel coronavirus diagnostics test

    Medical Dialogues Bureau20 Feb 2020 3:16 PM IST
    Paris, France and Camberley: Novacyt an international specialist in clinical diagnostics recently announced that its molecular diagnostics...
    Drug marketers to take onus for quality of drugs, regulatory compliance: Health Ministry Gazette

    Drug marketers to take onus for quality of drugs, regulatory compliance: Health Ministry Gazette

    Farhat Nasim19 Feb 2020 2:40 PM IST
    New Delhi: Through a recent gazette notification, the Union Health Ministry has amended the Drugs and Cosmetics Rules, 1945, wherein, drug...
    USFDA, Indian Government Join hands to clamp down on Illicit Medical Products

    USFDA, Indian Government Join hands to clamp down on Illicit Medical Products

    Medical Dialogues Bureau19 Feb 2020 12:54 PM IST
    US: The U.S. Food and Drug Administration today announced that its first bilateral enforcement operation with the Government of India stopped...
    PrevNext

    Popular Stories

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    India should become self-reliant in medical equipment, devices: Kasturirangan

    India should become self-reliant in medical equipment, devices: Kasturirangan

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Metropolis Healthcare Q2 profit up 44 pc to Rs 43 crore

    Metropolis Healthcare Q2 profit up 44 pc to Rs 43 crore

    Capacit

    Capacit'e Infraprojects bags Rs 407 crore order in Mumbai

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok